Herbal Oral Composition Using Nanovesicles for Bioactive Co-Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oral compositions fail to integrate multiple bioactive modalities such as standardized herbal concentrates, mushroom extracts, marine collagen, and plant-derived nanovesicles in a cohesive and scalable manner, leading to suboptimal efficacy for musculoskeletal health due to bioavailability challenges and inconsistent release profiles.
Innovation Solution
A herbal oral composition comprising a herbal concentrate, mushroom extract, marine collagen, 4-allylpyrocatechol, and plant-derived nanovesicles, manufactured through a method involving specific mixing and encapsulation processes to ensure synergistic interactions and optimized release profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple bioactive ingredients (herbal concentrates, mushroom extracts, marine collagen, 4-allylpyrocatechol) are integrated into a single oral composition, then the efficacy for musculoskeletal health is enhanced through synergistic interactions, but the manufacturing complexity and formulation difficulty increase significantly
Solution Approach 1:
The patent creates a composite oral composition integrating multiple bioactive ingredients (herbal concentrates, mushroom extracts, marine collagen, 4-allylpyrocatechol) with distinct functional properties. Each ingredient contributes specific benefits: herbal concentrates provide anti-inflammatory compounds, mushroom extracts offer immunomodulatory effects, marine collagen supports cartilage structure, and 4-allylpyrocatechol delivers potent analgesic activity. The composite formulation achieves synergistic therapeutic effects while maintaining manufacturability through standardized processing parameters.
Solution Approach 2:
The formulation is segmented into distinct functional modules, each containing specific bioactive ingredients with defined concentration ranges. This modular approach allows independent optimization of each ingredient's contribution while simplifying the overall manufacturing process. The segmented structure enables consistent quality control by treating each ingredient module as a separate entity with standardized specifications.
2Quantity of substance
If plant-derived nanovesicles are used to protect and enhance delivery of 4-allylpyrocatechol, then the bioavailability and stability are improved, but the manufacturing precision and process control requirements increase
Solution Approach 1:
Plant-derived nanovesicles serve as intermediary carriers that protect 4-allylpyrocatechol from degradation in the gastrointestinal tract and facilitate its delivery to target tissues. The nanovesicles act as a mediator between the labile phytochemical and the biological environment, enhancing stability and bioavailability while enabling controlled release. This intermediary approach simplifies manufacturing by using naturally formed nanovesicles rather than requiring complex synthetic encapsulation systems.
Solution Approach 2:
The patent utilizes parameter changes in the physical and chemical properties of 4-allylpyrocatechol through its interaction with plant-derived nanovesicles. The encapsulation process alters the dissolution rate, stability profile, and absorption characteristics of the phytochemical. By controlling parameters such as nanovesicle size distribution, surface charge, and encapsulation efficiency within defined ranges, the formulation achieves enhanced bioavailability while maintaining manufacturability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves enhanced musculoskeletal health by stabilizing marine collagen, protecting 4-allylpyrocatechol, and co-releasing active ingredients, providing consistent anti-inflammatory and regenerative effects.
Implementation Method 1
PDNVs have recently emerged as a biocompatible platform capable of protecting sensitive phytochemicals, enhancing mucosal uptake, and enabling targeted delivery
Implementation Method 2
Marine collagen, particularly low-molecular-weight fractions obtained from fish byproducts, has demonstrated promise in promoting cartilage matrix synthesis and reducing joint stiffness
Implementation Method 3
mushroom-derived β-glucan preparations (e.g., from Auricularia auricula, Tremella fuciformis, Lentinus edodes, Hericium erinaceus) have been shown to modulate immune responses and support cartilage health
Data Source
AI summary
A herbal oral composition having the properties for supporting and enhancing musculoskeletal health and processes for manufacturing the same from ingredients are disclosed comprising: a herbal concentrate having a first predetermined percentage (%) by weight, a herbal powder mixture having a second predetermined percentage (%) by weight, a mushroom extract ingredient having a third predetermined percentage (%) by weight, a collagen extract ingredient having a fourth percentage (%) by weight, a solution containing 4-allylpyrocatechol having a fifth percentage (%) by weight, and a plant-derived nanovesicles ingredient having a sixth percentage (%) by weight.